Viewing nowK-Myril Tablet 2 mg (Glibenclamide)
Glimepiride 2mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 200410907 · Notified 2004.11.05 · Insurance code 665000600
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be administered as monotherapy, and if blood sugar control is inadequate with oral hypoglycemic agents alone, it may be used in combination with insulin or other medications. Additionally, when control is not appropriate with sulfonylureas or metformin alone, it can be combined with metformin to enhance effectiveness. This treatment approach helps to effectively improve blood sugar levels.
The dosage should be adjusted individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, little additional benefit is seen with doses above 4 mg, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the amount of this medicine required may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previously administered medicine. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate treatment and follow-up by a physician and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) is above 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may be increased. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes or diabetic ketoacidosis, or patients in a comatose state. Patients who are allergic to this medication or its components, or those with severe liver or kidney dysfunction should not take it. It is advisable for pregnant women or those who may become pregnant and breastfeeding women to avoid this medication. In cases of severe infections or before/after surgery, or in cases of severe trauma, transitioning to insulin therapy is recommended. Disorders such as diarrhea or vomiting may impede the absorption of this medication, increasing the risk of hypoglycemia. During the first week of taking this medication, the risk of hypoglycemia is high, so blood sugar should be monitored frequently. This is particularly important for the elderly, individuals in poor nutritional status or with irregular meals, those with improper balance between exercise and diet, and frequent alcohol consumers. Patients with impaired liver or kidney function and those taking multiple medications should also closely monitor blood sugar changes. If hypoglycemic symptoms occur or if there is a high risk of hypoglycemia, dose adjustments or changes in administration may be necessary. Taking this medication can cause hypoglycemic symptoms, which may include headaches, severe hunger, nausea, fatigue, drowsiness, confusion, trembling, and dizziness. In severe cases, loss of consciousness or convulsions may occur, so if symptoms arise, immediate intake of sugar or consultation with medical personnel is necessary. Also, rare side effects such as visual impairment, indigestion, liver function abnormalities, blood disorders, and allergic reactions may occur, so any unusual symptoms should be reported promptly. Regular intake of this medication along with diet and exercise is essential for optimal blood sugar control. If hypoglycemia occurs, sugar or sugar-containing drinks should be consumed to rapidly elevate blood sugar; artificial sweeteners are not effective. Blood sugar control may become difficult during stressful situations, surgery, or infection, and temporary transition to insulin therapy may be required. Additionally, caution should be exercised while driving or operating machinery due to the risk of accidents from hypoglycemic or hyperglycemic symptoms. This medication interacts with many other drugs, which may impact blood sugar control depending on the medications taken concurrently. Special caution should be taken when used in combination with certain antibiotics, antifungals, antihypertensives, anti-inflammatory drugs, and beta-blockers, and it is important to inform the physician or pharmacist of all medications being used. Pregnant or breastfeeding women should avoid this medication due to potential effects on the fetus or newborn, and if necessary, insulin therapy is a safer alternative. This medication is not used in children under 18 years of age, as safety and efficacy have not been established. Elderly patients may have decreased kidney function, so dosage adjustments should be made as needed. In the case of an overdose, severe hypoglycemia may occur, and immediate medical attention should be sought for appropriate treatment.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language disorders, aphasia, visual disturbances, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitive reactions of the skin, decreased serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The temperature should be maintained between 1 and 30 degrees Celsius.
Green oblong tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.